US Patent

US9365514 — Composition comprising tetracyclic compound

Formulation · Assigned to Chugai Pharmaceutical Co Ltd · Expires 2032-03-04 · 6y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a composition that includes a poorly water-soluble tetracyclic compound, a carrier, and a dissolution aid.

USPTO Abstract

A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.

Drugs covered by this patent

Patent Metadata

Patent number
US9365514
Jurisdiction
US
Classification
Formulation
Expires
2032-03-04
Drug substance claim
No
Drug product claim
Yes
Assignee
Chugai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.